AL-38583
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-38583, covering 2012-03-06 to 2012-03-06. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge [Phase 2]